COMMUNIQUÉS West-GlobeNewswire

Gibson Oncology Announces First Patient Completes Initial Treatment Cycle in Phase II Trial of LMP744 for Recurrent Glioblastoma
11/08/2026
Novel Blood-Brain-Barrier-Penetrant Agent Being Evaluated as a Single Therapy in a Trial Conducted by the National Institute of Neurological Disorders and Stroke (NINDS) MIAMI, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Gibson [...]
Noah Medical Announces Galaxy™ II, the Next Dimension in Robotic-Assisted Bronchoscopy
11/08/2026
New functionality gives physicians the freedom to choose the right imaging for every case and a more responsive drive experience without adding capital, complexity, or radiation SAN JOSE, Calif., Aug. 11, 2026 (GLOBE [...]
Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update
11/08/2026
Expect to complete enrollment of the BCG-Unresponsive registrational cohort of the ADVANCED-2 trial in 4Q 2026 The ADVANCED-3 trial is being redesigned as an exploratory trial to expand into and accelerate data in high- [...]
NovelMed Advances Its Ocular Program, Highlighting the Potential of a Single Therapy Across Multiple Retinal Diseases
11/08/2026
--- A Versatile Complement Therapy Across Ocular, Hematologic, Renal, Dermatological, and Inflammatory Disorders. Key Highlights Commercial Precedent for One Molecule, Two Diseases : Biogen’s $5.6 billion acquisition of [...]
Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
11/08/2026
Sentynl expands its rare disease portfolio with potential first-in-class oral treatment for AATD-LD, a rare genetic respiratory disease On option exercise, Sentynl will have the right to commercialize the product in the [...]
Anavex Life Sciences Highlights Highly Qualified Board and Decisive Actions to Create Long-Term Value for Stockholders
11/08/2026
Files Definitive Proxy Statement and Mails Letter to Stockholders Urges Stockholders to Vote "FOR" All Six Anavex Director Nominees on the WHITE Proxy Card Underscores PVG’s Lack of Clear Plan and Inexperienced Slate of [...]
LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
11/08/2026
Announced accelerated timing of topline data readout from the pivotal Phase 3 NOVA-2 trial of LB-102 in schizophrenia in the first half of 2027 Announced plans for pipeline expansion of LB-102 into new neuropsychiatric [...]
Frishantic Introduces New Magnesium Complex for Women, Combining Seven Magnesium Forms with L-Theanine and Vitamin B6
11/08/2026
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Frishantic , a wellness brand focused on practical daily nutrition solutions, has introduced its new Magnesium Complex for Women , a multi-ingredient supplement designed to [...]
SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma
11/08/2026
TAIPEI, Taiwan, Aug. 11, 2026 (GLOBE NEWSWIRE) -- SL Science Holding Limited (“SL Science” or the “Company”) (Nasdaq: SLBT), a Taiwan-headquartered biomedical company specializing in developing innovative cellular and [...]
Theriva™ Biologics Reports Second Quarter 2026 Operational Highlights and Financial Results
11/08/2026
– First patients dosed in the VIRAGE2 Phase 2a clinical study evaluating more frequent repeated dosing of VCN-01 (zabilugene almadenorepvec) the goal of which is to improve treatment outcomes in metastatic pancreatic [...]
Nu-Tek BioSciences obtient la Médaille de bronze décernée par EcoVadis pour la troisième année consécutive, consolidant ainsi son statut de fournisseur biopharmaceutique respectueux de l’environnement
11/08/2026
Cette distinction d’EcoVadis vient renforcer l’engagement continu de Nu-Tek en faveur de la fabrication durable de nutriments pour milieux de culture cellulaire et d’ingrédients de fermentation sans composants d’origine [...]
Nu-Tek BioSciences Earns EcoVadis Bronze Rating for Third Consecutive Year, Strengthening Sustainable Biopharmaceutical Supplier Status
11/08/2026
EcoVadis recognition reinforces Nu-Tek's sustained investment in the sustainable manufacturing of animal-origin-free cell culture media nutrients and fermentation ingredients. MINNETONKA, Minn., Aug. 11, 2026 (GLOBE [...]
Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy
11/08/2026
TEL AVIV, Israel, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Moody’s Ratings has upgraded Teva’s corporate credit rating to Baa3 from Ba1, an [...]
Clearmind Medicine Announces Positive Permeation Results for Intranasal MEAI Formulation, Supporting Enhanced Nasal Retention Without Compromising Drug Delivery
11/08/2026
Vancouver, Canada, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND, FSE: CWY0) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, [...]
Flyte Partners with The Nucleus Network for Inaugural Flagship Founder & Investor Event
11/08/2026
Strategic Partnership Places Flyte at the Center of One of the Nation's Premier Communities of Founders, Investors, and Operators Collaboration Reflects Flyte's Continued Commitment to Building Relationships Within the [...]
Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
11/08/2026
Entered into option and license agreement with Sentynl Therapeutics for alvelestat, Mereo’s investigational oral therapy for Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD) Mereo and partner Ultragenyx [...]
PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101
11/08/2026
PDS0301 Phase 2 clinical data in mCRC and a comprehensive review of capital allocation priorities drive strategic refocus designed to maximize long-term shareholder value PRINCETON, N.J., Aug. 11, 2026 (GLOBE NEWSWIRE [...]
Introducing Veritas24-7™ – A New Way for Pharmaceutical Companies to Engage Physicians 24 Hours a Day
11/08/2026
Through lifelike AI personas, Veritas24-7 provides physicians with immediate 24 hours a day access to company-approved Medical Science Liaison and Sales Representative expertise through natural, face-to-face, two-way [...]
Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
11/08/2026
Closed a private placement of up to $354 million, with $180 million upfront and up to $174 million from warrants exercisable prior to and up to 20 trading days following FDA approval Strengthened organization with new [...]

Pages